Search

Betahistine mesylate INN 6mg/tabletInd; C/I; S/E; Cautions: See above under thetext.Dosage & admin: The usual initial dose is 6mg to 12mg 3 times daily taken preferably after meals. The dosage may be adjusted depending on the patient's age and symptoms. Maintenance dosage may be given up to 36mg dai..

Truxil 30/10 mg TabIndication:Reduces Neurological damage & accelerates recovery after stroke, Minor age related neurological disorders, Visual disorders related to age, Disorders in the inners ear (hearing loss, dizziness, buzzing etc.)Dosage & Administration:Truxil™ 1-2 tablets daily (with a sever..

Bromodel 2.5 mg tab..

Criptine Tab..

DescriptionImatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase; the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in CML. Imatinib inhibits proliferation and induces apoptosis in BCR-ABL positive cell lines as ..

Imacent 400 Tablet DescriptionImatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase; the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in CML. Imatinib inhibits proliferation and induces apoptosis in BCR-ABL..

DescriptionLenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer prog..

Lenvacent 4 CapsuleDescriptionLenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor grow..

Osicent80 TabletDescriptionOsimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. In cultured cells and animal tumor imp..

DescriptionOsimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. In cultured cells and animal tumor implantation models..